Literature DB >> 18316065

VPA-induced apoptosis and behavioral deficits in neonatal mice.

Carrie L Yochum1, Peter Dowling, Kenneth R Reuhl, George C Wagner, Xue Ming.   

Abstract

Sodium valproate (VPA) administered to neonatal mice causes cognitive and motor deficits similar to those observed in humans with autism. In an effort to further evaluate similarities between early VPA exposure and autism, the present study examined treated mice for deficits in social behavior and neuronal damage. BALB/c mice injected on P14 with 400 mg/kg VPA engaged in fewer social interactions (including ano-genital sniffs, allogrooming, and crawl-under/over behaviors) than control mice. Treated mice also exhibited reduced motor activity in a social context but were not significantly different from controls when motor activity was assessed in non-social settings. A second set of BALB/c mice were treated with VPA on P14 and sacrificed at different times thereafter for histopathological analysis. At time-points 12 and 24 h following VPA, treated mice had up to a 30-fold increase in the number of TUNEL-positive cells in the external granule cell layer of the cerebellum and a 10-fold increase in TUNEL-positive cells in the dentate gyrus of the hippocampus. These observations may provide a histopathological correlate for the social deficits observed following post-natal VPA exposure and supports the use of early VPA administration as an animal model for the study of autism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316065     DOI: 10.1016/j.brainres.2008.01.055

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  33 in total

1.  Altered behavioral development in Nrf2 knockout mice following early postnatal exposure to valproic acid.

Authors:  Melody A Furnari; Constance Lay-Lay Saw; Ah-Ng Kong; George C Wagner
Journal:  Brain Res Bull       Date:  2014-10-20       Impact factor: 4.077

2.  Valproic acid induces neuronal cell death through a novel calpain-dependent necroptosis pathway.

Authors:  Dominique Bollino; Irina Balan; Laure Aurelian
Journal:  J Neurochem       Date:  2015-02-08       Impact factor: 5.372

3.  Effect of early postnatal exposure to valproate on neurobehavioral development and regional BDNF expression in two strains of mice.

Authors:  Kevin G Bath; Tiare Pimentel
Journal:  Epilepsy Behav       Date:  2017-04-13       Impact factor: 2.937

4.  Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats.

Authors:  T Sandhya; J Sowjanya; B Veeresh
Journal:  Neurochem Res       Date:  2012-02-10       Impact factor: 3.996

Review 5.  Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum.

Authors:  Alexey V Shevelkin; Chinezimuzo Ihenatu; Mikhail V Pletnikov
Journal:  Rev Neurosci       Date:  2014       Impact factor: 4.353

Review 6.  Psychoactive drug exposure during breastfeeding: a critical need for preclinical behavioral testing.

Authors:  Irving Zucker
Journal:  Psychopharmacology (Berl)       Date:  2018-03-16       Impact factor: 4.530

7.  Impaired social behavior in chicks exposed to sodium valproate during the last week of embryogenesis.

Authors:  Hideo Nishigori; Keisuke Kagami; Ai Takahashi; Yu Tezuka; Atsushi Sanbe; Hidekazu Nishigori
Journal:  Psychopharmacology (Berl)       Date:  2013-01-31       Impact factor: 4.530

8.  Effects of developmental alcohol and valproic acid exposure on play behavior of ferrets.

Authors:  Thomas E Krahe; Claudio C Filgueiras; Alexandre E Medina
Journal:  Int J Dev Neurosci       Date:  2016-05-18       Impact factor: 2.457

9.  Postnatal Stress Induced by Injection with Valproate Leads to Developing Emotional Disorders Along with Molecular and Cellular Changes in the Hippocampus and Amygdala.

Authors:  Chih-Yen Wang; Chien-Wen Cheng; Wei-Hua Wang; Po-See Chen; Shun-Fen Tzeng
Journal:  Mol Neurobiol       Date:  2015-12-11       Impact factor: 5.590

Review 10.  Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.

Authors:  Kevin G Bath; Helen E Scharfman
Journal:  Epilepsy Behav       Date:  2013-01-08       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.